http://www.astrazeneca.com.tw:80/news-centre/newsroom/ Subscribe for RSS zh zh http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946025&user_locale=zh 兩篇第2期試驗的結果有助於瞭解Brilinta (Ticagrelor)以及它在體內的作用 Wed, 18 Nov 2009 07:01:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946025&user_locale=zh 2009-11-18T07:01:00Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946023&user_locale=zh 美國食品藥物管理局核准CRESTOR用於異型接合子家族性高膽固醇血症小兒病患 Fri, 16 Oct 2009 06:38:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946023&user_locale=zh 2009-10-16T06:38:00Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946021&user_locale=zh 【2009.10.02】研究顯示：Dapagliflozin可顯著改善以Metformin控制不佳之第2型糖尿病患的血糖和體重 Fri, 02 Oct 2009 02:19:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946021&user_locale=zh 2009-10-02T02:19:00Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946012&user_locale=zh 【2009.09.28】Seroquel XR與Seroquel在歐洲獲得核准用於預防躁鬱症復發 Mon, 28 Sep 2009 02:05:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946012&user_locale=zh 2009-09-28T02:05:00Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946008&user_locale=zh 【2009.09.25】Brilinta減少接受心臟手術之ACS病患的心血管疾病死亡與心臟病發作：PLATO試驗的新資料 Fri, 25 Sep 2009 08:58:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946008&user_locale=zh 2009-09-25T08:58:00Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946010&user_locale=zh 【2009.09.25】美國上訴法庭證實Seroquel專利訴訟的簡易判決 Fri, 25 Sep 2009 02:02:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946010&user_locale=zh 2009-09-25T02:02:00Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946006&user_locale=zh 【2009.09.21】阿斯特捷利康藥廠與Nektar簽署全球的Nektar藥物研發計畫協議 治療鴉片引起的便秘 Mon, 21 Sep 2009 02:54:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946006&user_locale=zh 2009-09-21T02:54:00Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946004&user_locale=zh 【2009.08.31】阿斯特捷利康藥廠宣布FDA接受VIMOVO的新藥申請 Mon, 31 Aug 2009 02:51:33 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946004&user_locale=zh 2009-08-31T02:51:33Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946002&user_locale=zh 第III期臨床研究顯示，對於急性冠狀症候群病患，Ticagrelor降低心血管死亡以及心臟病發作的效果優於Clopidogrel Sun, 30 Aug 2009 01:00:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946002&user_locale=zh 2009-08-30T01:00:00Z http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946000&user_locale=zh 阿斯特捷利康藥廠與Forest實驗室今天宣布，他們達成明確的合作協議，將共同發展ceftaroline以及在美國、加拿大和日本之外的所有市 場行銷。 Wed, 12 Aug 2009 01:00:00 GMT http://www.astrazeneca.com.tw:80/news-centre/newsroom/?itemId=10946000&user_locale=zh 2009-08-12T01:00:00Z